Becigard 7.5mg Tablet
Marketer
Cipla Ltd
Salt Composition
Darifenacin (7.5mg)
Overview Becigard 7.5mg Tablet
Oxibutinine 7.5mg tablets, a muscarinic receptor blocker, are prescribed for overactive bladder syndrome. This medication alleviates symptoms such as urinary frequency, urgency, and incontinence. Always adhere to your physician's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal results. Common side effects include constipation, headache, dry mouth, urinary tract infection, nausea, and dry nose. Report any persistent or bothersome side effects to your doctor promptly; they can offer strategies for managing them. Before starting treatment, disclose all current medications and any pre-existing medical conditions. Inform your doctor if you are pregnant or breastfeeding. This medication is contraindicated in patients with severe hepatic impairment; seek medical advice before use.
Uses of Becigard 7.5mg Tablet
Managing overactive bladder (OAB) symptoms
Major Benefits of Becigard 7.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Becigard 7.5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Becigard 7.5mg Tablet:
- Constipation
- Dryness in mouth
- Headache
- Dry eye
- Nasal dryness
How to use Becigard 7.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Becigard 7.5mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Becigard 7.5mg Tablet works:
Urinary incontinence can be managed with Becigard 7.5mg tablets, an antimuscarinic agent. These tablets ease bladder muscle contractions, reducing the frequency, urgency, and involuntary voiding of urine.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Becigard 7.5mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Becigard 7.5mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Becigard 7.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Becigard 7.5mg Tablet side effects. These side effects can include dizziness, blurred vision, insomnia, or drowsiness, potentially impacting driving safety.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Becigard 7.5mg tablets are considered safe, and no dosage alteration is needed. Nevertheless, disclosure of any pre-existing kidney condition to your physician is advisable.
LiverCAUTION
Patients with severe hepatic impairment should use Becigard 7.5mg tablets cautiously. Dosage modification for Becigard 7.5mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Becigard 7.5mg Tablet :
Should you forget a Becigard 7.5mg Tablet dose, take it immediately if you remember. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Becigard 7.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Diphenylmethane-based compound |
| Developing Habits | No. |
| Treatment Category | Urologic Care |
3,018 People bought this recently